Loading clinical trials...
Loading clinical trials...
Predictors and Survival in Pulmonary Hypertension Associated With Severe Lung Disease
First, the aim of the study was to evaluate the usefulness of echocardiographic parameters for detecting pulmonary hypertension (PH) in patients with advanced lung disease referred for lung transplantation. Second, to assess the prevalence of PH and to identify which hemodynamic, echocardiographic, pulmonary functional test, exercise capacity and biochemical parameters (especially NT-proBNP) have an impact on survival in a cohort of patients with severe lung diseases referred for lung transplantation.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Silesian Centre for Heart Diseases
Zabrze, Silesian Voivodeship, Poland
Start Date
December 1, 2008
Primary Completion Date
April 1, 2020
Completion Date
April 1, 2023
Last Updated
May 27, 2020
200
ESTIMATED participants
Lead Sponsor
Silesian Centre for Heart Diseases
NCT07073820
NCT06899815
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07462260